MXRA5 and central nervous system cancer: Additionally, Cox univariate and multivariate analyses of MXRA5 expression and clinicopathological features revealed that MXRA5 expression has a correlation with age and WHO pathological stage, suggesting that MXRA5 could be an independent prognostic factor for glioma patients.